BACKGROUND: Patients with hereditary haemochromatosis (HH) are usually homozygous for the C282Y mutation in the HFE gene. They have variable expression of iron overload and present with a variety of complications, including liver disease, diabetes, arthropathy, fatigue, and cardiomyopathy. The mitochondrial 16189 variant is associated with diabetes, dilated cardiomyopathy, and low body fat at birth, and might contribute to genetic predisposition in further multifactorial disorders. The objective of this study was to determine the frequency of the 16189 variant in a range of patients with haemochromatosis, who had mutations in the HFE gene. METHODS: Blood DNA was analysed for the presence of the 16189 variant in British, French, and Australian C282Y homozygotes and controls, with known iron status, and in birth cohorts. RESULTS: The frequency of the mitochondrial 16189 variant was found to be elevated in individuals with haemochromatosis who were homozygous for the C282Y allele, compared with population controls and with C282Y homozygotes who were asymptomatic (42/292 (14.4%); 102/1186 (8.6%) (p = 0.003); and 2/64 (3.1%) (p = 0.023), respectively). CONCLUSIONS: Iron loading in C282Y homozygotes with HH was exacerbated by the presence of the mitochondrial 16189 variant.
BACKGROUND:Patients with hereditary haemochromatosis (HH) are usually homozygous for the C282Y mutation in the HFE gene. They have variable expression of iron overload and present with a variety of complications, including liver disease, diabetes, arthropathy, fatigue, and cardiomyopathy. The mitochondrial 16189 variant is associated with diabetes, dilated cardiomyopathy, and low body fat at birth, and might contribute to genetic predisposition in further multifactorial disorders. The objective of this study was to determine the frequency of the 16189 variant in a range of patients with haemochromatosis, who had mutations in the HFE gene. METHODS: Blood DNA was analysed for the presence of the 16189 variant in British, French, and Australian C282Y homozygotes and controls, with known iron status, and in birth cohorts. RESULTS: The frequency of the mitochondrial 16189 variant was found to be elevated in individuals with haemochromatosis who were homozygous for the C282Y allele, compared with population controls and with C282Y homozygotes who were asymptomatic (42/292 (14.4%); 102/1186 (8.6%) (p = 0.003); and 2/64 (3.1%) (p = 0.023), respectively). CONCLUSIONS:Iron loading in C282Y homozygotes with HH was exacerbated by the presence of the mitochondrial 16189 variant.
Authors: H A Jackson; K Carter; C Darke; M G Guttridge; D Ravine; R D Hutton; J A Napier; M Worwood Journal: Br J Haematol Date: 2001-08 Impact factor: 6.998
Authors: Thorvardur R Halfdanarson; Liang Wang; William R Bamlet; Mariza de Andrade; Robert R McWilliams; Julie M Cunningham; Gloria M Petersen Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-09 Impact factor: 4.254
Authors: Steven E Lipshultz; Stuart R Lipsitz; Jeffery L Kutok; Tracie L Miller; Steven D Colan; Donna S Neuberg; Kristen E Stevenson; Mark D Fleming; Stephen E Sallan; Vivian I Franco; Jacqueline M Henkel; Barbara L Asselin; Uma H Athale; Luis A Clavell; Bruno Michon; Caroline Laverdiere; Eric Larsen; Kara M Kelly; Lewis B Silverman Journal: Cancer Date: 2013-07-16 Impact factor: 6.860
Authors: K J H Robson; A T Merryweather-Clarke; E Cadet; V Viprakasit; M G Zaahl; J J Pointon; D J Weatherall; J Rochette Journal: J Med Genet Date: 2004-10 Impact factor: 6.318
Authors: Edith E Mueller; Waltraud Eder; Sabine Ebner; Eva Schwaiger; Danijela Santic; Tanja Kreindl; Olaf Stanger; Bernhard Paulweber; Bernhard Iglseder; Hannes Oberkofler; Richard Maier; Johannes A Mayr; Franz Krempler; Raimund Weitgasser; Wolfgang Patsch; Wolfgang Sperl; Barbara Kofler Journal: PLoS One Date: 2011-01-26 Impact factor: 3.240